AU4690999A - Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers - Google Patents

Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers

Info

Publication number
AU4690999A
AU4690999A AU46909/99A AU4690999A AU4690999A AU 4690999 A AU4690999 A AU 4690999A AU 46909/99 A AU46909/99 A AU 46909/99A AU 4690999 A AU4690999 A AU 4690999A AU 4690999 A AU4690999 A AU 4690999A
Authority
AU
Australia
Prior art keywords
diaminopyrimidines
treatment
combination therapies
positive cancers
therapies effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46909/99A
Other languages
English (en)
Inventor
David Allen Berry
Ellen Myra Dobrusin
Judith Lynne Johnson Philipsen
Wayne Daniel Klohs
Dennis Joseph Mcnamara
Leslie Morton Werbel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU4690999A publication Critical patent/AU4690999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU46909/99A 1998-08-13 1999-06-18 Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers Abandoned AU4690999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9643498P 1998-08-13 1998-08-13
US60096434 1998-08-13
PCT/US1999/013669 WO2000009131A1 (fr) 1998-08-13 1999-06-18 Diaminopyrimidines et polytherapies pour traiter efficacement les cancers positifs pour la glycoproteine p

Publications (1)

Publication Number Publication Date
AU4690999A true AU4690999A (en) 2000-03-06

Family

ID=22257335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46909/99A Abandoned AU4690999A (en) 1998-08-13 1999-06-18 Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers

Country Status (2)

Country Link
AU (1) AU4690999A (fr)
WO (1) WO2000009131A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138955A2 (fr) 2009-05-29 2010-12-02 University Of Florida Research Foundation, Inc. Procédés et compositions pour traiter la néoplasie
DE102012200333A1 (de) 2012-01-11 2013-07-11 Henkel Ag & Co. Kgaa Acylhydrazone als bleichverstärkende Wirkstoffe
EA201891766A1 (ru) * 2016-02-05 2019-02-28 ВИЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Композиции и способы для лечения инфекций
CN111225908A (zh) * 2017-08-07 2020-06-02 维耶拉制药有限责任公司 Dhfr抑制剂、组合物及其相关方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532240A (en) * 1982-09-09 1985-07-30 Warner-Lambert Company Diaminopyrimidines

Also Published As

Publication number Publication date
WO2000009131A1 (fr) 2000-02-24

Similar Documents

Publication Publication Date Title
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU3891299A (en) Combination therapy for treatment of depression
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU6151899A (en) Methods of treating chronic pain
AU1556497A (en) Agents for the treatment and prevention of aids
AU4218400A (en) Lyophilized solid dosage forms and methods of making
GB9811598D0 (en) Diagnosis and treatment of cancer
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU4690999A (en) Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
IL141211A0 (en) Prevention and treatment of viral disease
AU2964199A (en) Prevention and treatment of adhesions
AU5946999A (en) Tumour therapy and imaging
AU1200100A (en) Inhalation chemotherapy for prevention and treatment of metastatic tumors in thelung
AU2566201A (en) Compounds and methods for the treatment of pain
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase